Walleye Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Walleye Capital's RGEN Position: Q3 2026 in Review
Walleye Capital increased its Repligen (RGEN) stake by 1,385% in Q3 2026, buying an estimated $3.84M and bringing the position to 25,345 shares worth $4.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1925.
Walleye Capital first reported a position in RGEN in Q2 2019 and has held it in 17 quarters since. The position peaked at $68.3M in Q4 2025. 525 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Walleye Capital held 25,345 shares of Repligen worth $4.87M as of Q3 2026.
- Walleye Capital bought 23,638 Repligen shares in Q3 2026, an estimated $3.84M.
- Repligen made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #1925 holding.
- Walleye Capital first reported a position in Repligen in Q2 2019 and has held it in 17 quarters since.
- Walleye Capital's Repligen position peaked at $68.3M in Q4 2025.
- 525 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.